Glenmark In Pact With Novartis For Three Respiratory Drugs In Brazil
While Novartis will manufacture these respiratory drugs, Glenmark will look into their distribution in Brazil. (Photographer: Ariana Lindquist/Bloomberg)

Glenmark In Pact With Novartis For Three Respiratory Drugs In Brazil

Bookmark
Drugmaker Glenmark Pharmaceuticals Ltd. on Monday said that its subsidiary Glenmark Farmacutica has entered into an exclusive partnership with Novartis Biosciences SA for three respiratory products...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.